These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2240497)
61. [Diagnosis of susceptibility to malignant hyperthermia in children]. Krivosic-Horber R; Adnet P; Krivosic I; Reyford H Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268 [TBL] [Abstract][Full Text] [Related]
62. [Diagnosis of rhabdomyolysis in alcoholism]. Schwab W Acta Med Austriaca; 1982; 9(4):159-62. PubMed ID: 7136475 [TBL] [Abstract][Full Text] [Related]
63. Clinical, electrophysiological and pathological studies on malignant hyperpyrexia. Bradley WG; Ward M; Murchison D; Hall L; Woolf N Proc R Soc Med; 1973 Jan; 66(1 Pt 1):67-8. PubMed ID: 4690062 [No Abstract] [Full Text] [Related]
64. A case of malignant hyperthermia? Broekema AA; Boersma GA; Hennis PJ Anaesthesia; 1991 Nov; 46(11):942-5. PubMed ID: 1750596 [TBL] [Abstract][Full Text] [Related]
66. ["Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl)]. Malz H; Gullotta F; Klein H; Aebert K Anaesthesist; 1982 May; 31(5):248-51. PubMed ID: 7103033 [TBL] [Abstract][Full Text] [Related]
67. Body building and rhabdomyolysis. Doriguzzi C; Palmucci L; Mongini T J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):806-7. PubMed ID: 2246667 [No Abstract] [Full Text] [Related]
68. [Malignant hyperthermia. An unusual course of a rare disease]. Helms U; Kahle M; Fink KW; Heilmann K Anaesthesist; 1988 Apr; 37(4):277-81. PubMed ID: 3407897 [TBL] [Abstract][Full Text] [Related]
69. [Morphology of the muscles and brain in case of malignant hyperthermia]. Kozłowski PB Patol Pol; 1980; 31(1):147-52. PubMed ID: 7393646 [No Abstract] [Full Text] [Related]
70. [Isolated postoperative myoglobinuria as the only sign of malignant hyperthermia. Value of spinal anesthesia with bupivacaine in a posterior surgical intervention]. Pagani I; Ramaioli F; Belforti F; Parrini S; Raimondi M Minerva Anestesiol; 1992 Apr; 58(4):213-7. PubMed ID: 1620419 [TBL] [Abstract][Full Text] [Related]
72. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia. Isaacs H; Badenhorst M Anesthesiology; 1993 Jul; 79(1):5-9. PubMed ID: 8342829 [TBL] [Abstract][Full Text] [Related]
73. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations. Lewandowski KB Br J Anaesth; 1981 Sep; 53(9):981-4. PubMed ID: 7284224 [No Abstract] [Full Text] [Related]
74. Triggering agents continued after masseter spasm: there is proof in this pudding! van der Spek AF Anesth Analg; 1991 Sep; 73(3):364-5. PubMed ID: 1867439 [No Abstract] [Full Text] [Related]
75. Evidence of malignant hyperthermia in patients administered triggering agents before malignant hyperthermia susceptibility identified: missed opportunities prior to diagnosis. Chan TY; Bulger TF; Stowell KM; Gillies RL; Langton EE; Street NE; Pollock NA Anaesth Intensive Care; 2017 Nov; 45(6):707-713. PubMed ID: 29137581 [TBL] [Abstract][Full Text] [Related]
76. Dominantly inherited malignant hyperthermia (MH) in the King-Denborough syndrome. Isaacs H; Badenhorst ME Muscle Nerve; 1992 Jun; 15(6):740-2. PubMed ID: 1508238 [TBL] [Abstract][Full Text] [Related]
77. Masseter muscle spasm in children: implications of continuing the triggering anesthetic. Littleford JA; Patel LR; Bose D; Cameron CB; McKillop C Anesth Analg; 1991 Feb; 72(2):151-60. PubMed ID: 1898685 [TBL] [Abstract][Full Text] [Related]